Therapeutic antibodies for treating lung cancer
US12331133B2 · kind B2 · utility
0Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2020 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Oct 15, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies and uses thereof for treating lung cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.